NEW YORK, Aug 11 ― Antibody levels are a good predictor for how effective Moderna Inc's Covid-19 vaccine is, according to a new study released on Tuesday, a finding which could help speed up future clinical trials for vaccines against the disease. Regulators currently rely on large...
NEW YORK, Aug 11 ― Antibody levels are a good predictor for how effective Moderna Inc's Covid-19 vaccine is, according to a new study released on Tuesday, a finding which could help speed up future clinical trials for vaccines against the disease.
The study, which has not yet been peer-reviewed, found that the Moderna vaccine was more effective in vaccine recipients with high levels of antibodies. These recipients also reported a lower rate of breakthrough infections after being vaccinated.